Cytori Therapeutics (CYTX +6%) moves up after announcing its begun its Athena clinical trial to investigate it's cell therapy in patients who suffer from a severe form of untreatable heart failure due to chronic myocardial ischemia. The first patient was treated at the Minneapolis Heart Institute Foundation in September and has already undergone a seven day follow-up assessment.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs